Ayşegül Şeyma Sarıtaş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ayşegül Şeyma Sarıtaş has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Ayşın Kısabay Ak
Department of Neurology, Celal Bayar University, Manisa, Turkey
13 shared publications - Yağmur İnalkaç Gemici
Department of Neurology, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye
9 shared publications - Melike Batum
Department of Neurology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Türkiye
8 shared publications - Burcu Gökçe Çokal
Department of Neurology, Ankara Training and Research Hospital, University of Health Sciences, Ankara 06230, Turkey
3 shared publications - Hatice Mavioğlu
Department of Neurology, Manisa Celal Bayar University, Manisa, Turkey
3 shared publications - Neşe Çelebisoy
Ege University Medical School
3 shared publications
Latest Publications
- 30 November 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
TWO DISTINCT MECHANISMS, ONE OUTCOME: ELECTROPHYSIOLOGICAL TRACES OF PERIPHERAL NERVES IN DIABETES MELLITUS AND RHEUMATOID ARTHRITIS
Introduction: Diabetes mellitus (DM) and rheumatoid arthritis (RA) affect the peripheral nervous system through distinct mechanisms, leading to polyneuropathy (PNP). This study compared nerve conduction studies in DM and RA patients, evaluating subgroups by PNP status. Methods: Electrophysiological examinations performed between 2015 and 2025 were retrospectively reviewed, including 208 DM and 96 RA patients. Motor and sensory conduction parameters of the median, ulnar, sural, and fibular nerves were assessed. Patients were classified as PNP+ or PNP–. Group differences were analyzed, risk factors identified with logistic regression, and significant parameters tested with ROC analysis. Results: In DM, conduction velocities were reduced, distal latencies prolonged, and amplitudes decreased (p<0.05). In RA, parameters were relatively preserved, with higher amplitudes than DM. Among PNP+ patients, DM showed more severe involvement; sural nerve velocity <34.5 m/s was discriminatory for DM (AUC=0.771; specificity 85.1%) from RA. In RA, PNP was mainly sensory and strongly associated with female sex (OR=7.51, 95% CI: 3.36–16.80). In PNP– patients, no major differences were found, though RA showed entrapment/demyelinating features and DM subclinical small fiber involvement. Conclusion: DM is characterized by widespread axonal degeneration, whereas RA presents heterogeneous and milder neuropathic patterns. These differences may aid differential diagnosis and prognostic evaluation. Sural nerve conduction velocity appears particularly promising as a biomarker
- 30 November 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
TWO DISTINCT MECHANISMS, ONE OUTCOME: ELECTROPHYSIOLOGICAL TRACES OF PERIPHERAL NERVES IN DIABETES MELLITUS AND RHEUMATOID ARTHRITIS
Introduction: Diabetes mellitus (DM) and rheumatoid arthritis (RA) affect the peripheral nervous system through distinct mechanisms, leading to polyneuropathy (PNP). This study compared nerve conduction studies in DM and RA patients, evaluating subgroups by PNP status. Methods: Electrophysiological examinations performed between 2015 and 2025 were retrospectively reviewed, including 208 DM and 96 RA patients. Motor and sensory conduction parameters of the median, ulnar, sural, and fibular nerves were assessed. Patients were classified as PNP+ or PNP–. Group differences were analyzed, risk factors identified with logistic regression, and significant parameters tested with ROC analysis. Results: In DM, conduction velocities were reduced, distal latencies prolonged, and amplitudes decreased (p<0.05). In RA, parameters were relatively preserved, with higher amplitudes than DM. Among PNP+ patients, DM showed more severe involvement; sural nerve velocity <34.5 m/s was discriminatory for DM (AUC=0.771; specificity 85.1%) from RA. In RA, PNP was mainly sensory and strongly associated with female sex (OR=7.51, 95% CI: 3.36–16.80). In PNP– patients, no major differences were found, though RA showed entrapment/demyelinating features and DM subclinical small fiber involvement. Conclusion: DM is characterized by widespread axonal degeneration, whereas RA presents heterogeneous and milder neuropathic patterns. These differences may aid differential diagnosis and prognostic evaluation. Sural nerve conduction velocity appears particularly promising as a biomarker
- 15 October 2026
- Published by Springer Nature in Acta Neurologica Belgica
- p. 1-9
Clinical characteristics of headache in the patients with Neuro-Behçet’s disease
- 15 October 2026
- Published by Springer Nature in Acta Neurologica Belgica
- p. 1-9
Clinical characteristics of headache in the patients with Neuro-Behçet’s disease
- 11 September 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (10) , 773
Oligoclonal band count as a marker of MRI lesion burden and clinical profile in newly diagnosed multiple sclerosis
Background and purpose Oligoclonal band (OCB) positivity is a well-established biomarker in multiple sclerosis (MS), yet the clinical and radiological relevance of OCB count remains unclear. Although magnetic resonance imaging (MRI) markers reflect disease burden, it is unknown whether OCB count parallels MRI-defined lesion distribution and early cognitive involvement. We investigated associations between OCB count and demographic, clinical, radiological, and cognitive features in newly diagnosed MS. Methods We evaluated 62 newly diagnosed MS patients and 59 controls. Cerebrospinal fluid OCB count was analyzed as a continuous variable. Associations with MRI features—lesion distribution (Mtotal), T1-hypointense and gadolinium-enhancing lesions, and spinal cord involvement—and cognitive performance (SDMT, BVMT-R, CVLT-II) were assessed using correlation, subgroup comparisons, and multivariable regression. Results Higher OCB counts were independently associated with IgG index (β = 5.25, p = 0.004) and wider lesion dissemination (Mtotal; β = 1.57, p = 0.025). Coexisting spinal cord and T1-hypointense lesions were associated with higher OCB counts and showed a moderate effect size (η² = 0.092, p = 0.027). Mtotal was independently associated with CVLT-II performance (β = −3.221, p = 0.046), and OCB count correlated negatively with CVLT-II scores (r = − 0.266, p = 0.036). Conclusion In early, minimally disabled MS, higher OCB counts are associated with broader MRI lesion distribution and subtle impairment in verbal learning and memory. These findings suggest that OCB count reflects intrathecal immune activity that parallels MRI-defined lesion topography and may help identify patients with early radiological and cognitive vulnerability.
- 11 September 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (10) , 773
Oligoclonal band count as a marker of MRI lesion burden and clinical profile in newly diagnosed multiple sclerosis
Background and purpose Oligoclonal band (OCB) positivity is a well-established biomarker in multiple sclerosis (MS), yet the clinical and radiological relevance of OCB count remains unclear. Although magnetic resonance imaging (MRI) markers reflect disease burden, it is unknown whether OCB count parallels MRI-defined lesion distribution and early cognitive involvement. We investigated associations between OCB count and demographic, clinical, radiological, and cognitive features in newly diagnosed MS. Methods We evaluated 62 newly diagnosed MS patients and 59 controls. Cerebrospinal fluid OCB count was analyzed as a continuous variable. Associations with MRI features—lesion distribution (Mtotal), T1-hypointense and gadolinium-enhancing lesions, and spinal cord involvement—and cognitive performance (SDMT, BVMT-R, CVLT-II) were assessed using correlation, subgroup comparisons, and multivariable regression. Results Higher OCB counts were independently associated with IgG index (β = 5.25, p = 0.004) and wider lesion dissemination (Mtotal; β = 1.57, p = 0.025). Coexisting spinal cord and T1-hypointense lesions were associated with higher OCB counts and showed a moderate effect size (η² = 0.092, p = 0.027). Mtotal was independently associated with CVLT-II performance (β = −3.221, p = 0.046), and OCB count correlated negatively with CVLT-II scores (r = − 0.266, p = 0.036). Conclusion In early, minimally disabled MS, higher OCB counts are associated with broader MRI lesion distribution and subtle impairment in verbal learning and memory. These findings suggest that OCB count reflects intrathecal immune activity that parallels MRI-defined lesion topography and may help identify patients with early radiological and cognitive vulnerability.
- 1 August 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (8) , 673
A comparison of the effects of greater occipital nerve blockade and combined greater occipital–supraorbital nerve blockade on headache in chronic migraine
- 1 August 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (8) , 673
A comparison of the effects of greater occipital nerve blockade and combined greater occipital–supraorbital nerve blockade on headache in chronic migraine
- 17 June 2026
- Published by Necmettin Erbakan University in Selcuk Tip Dergisi
Association Between Sleep Problems and Quality of Life in Idiopathic Parkinson s Disease: Findings from Multiple Centers in Türkiye
Amaç: Bu çalışmada, Türkiye'de İdiyopatik Parkinson Hastalığı (İPH) olan hastalarda uyku bozukluklarının yaygınlığının araştırılması ve bu bozuklukların hastaların uyku ve yaşam kalitesini nasıl etkilediğinin belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Türkiye'de yürütülen bu çok merkezli çalışmada, 451 IPH hastası değerlendirildi. Hastaların demografik ve klinik verileri kaydedildi. Değerlendirmeler Parkinson Hastalığı Uyku Ölçeği, Parkinson Hastalığı Anketi ve Beck Depresyon Envanteri kullanılarak yapıldı. Bulgular: IPH tanısı olan 451 hastanın ortalama yaşı 69,13±11,27 yıldı. Modifiye Hoehn Yahr Ölçeği'ne göre en sık görülen hastalık evresi %24,8 ile evre 1 iken, en az görülen evre ise %1,3 ile evre 5 idi. Hastaların %30,6’sında orta şiddette depresyon, %29,9’unda minimal depresyon, %24,6’sında hafif depresyon, %14,9’unda ise ağır depresyon saptandı. Hasta yaşı arttıkça uyku başlangıcı ve uyku faydası puanları anlamlı derecede azaldı. Hastalık süresi ve evresi arttıkça uyku kalitesinin tüm alt parametrelerinde azalma görüldü. Yaşam kalitesi alt parametreleri ve toplam puanları arttıkça depresyon puanı da artmaktaydı. Yaşam kalitesi alt parametrelerinin tümü ile depresyon arasında güçlü pozitif korelasyon vardı (p<0,001). Sonuç: Uyku bozuklukları IPH hastalarında yaygındır ve depresyon ve yaşam kalitesini büyük ölçüde olumsuz etkiler. Parkinson hastalarında uyku bozukluklarının kontrol altına alınmasıyla yaşam kalitesi artırılabilir.
- 17 June 2026
- Published by Necmettin Erbakan University in Selcuk Tip Dergisi
Association Between Sleep Problems and Quality of Life in Idiopathic Parkinson s Disease: Findings from Multiple Centers in Türkiye
Amaç: Bu çalışmada, Türkiye'de İdiyopatik Parkinson Hastalığı (İPH) olan hastalarda uyku bozukluklarının yaygınlığının araştırılması ve bu bozuklukların hastaların uyku ve yaşam kalitesini nasıl etkilediğinin belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Türkiye'de yürütülen bu çok merkezli çalışmada, 451 IPH hastası değerlendirildi. Hastaların demografik ve klinik verileri kaydedildi. Değerlendirmeler Parkinson Hastalığı Uyku Ölçeği, Parkinson Hastalığı Anketi ve Beck Depresyon Envanteri kullanılarak yapıldı. Bulgular: IPH tanısı olan 451 hastanın ortalama yaşı 69,13±11,27 yıldı. Modifiye Hoehn Yahr Ölçeği'ne göre en sık görülen hastalık evresi %24,8 ile evre 1 iken, en az görülen evre ise %1,3 ile evre 5 idi. Hastaların %30,6’sında orta şiddette depresyon, %29,9’unda minimal depresyon, %24,6’sında hafif depresyon, %14,9’unda ise ağır depresyon saptandı. Hasta yaşı arttıkça uyku başlangıcı ve uyku faydası puanları anlamlı derecede azaldı. Hastalık süresi ve evresi arttıkça uyku kalitesinin tüm alt parametrelerinde azalma görüldü. Yaşam kalitesi alt parametreleri ve toplam puanları arttıkça depresyon puanı da artmaktaydı. Yaşam kalitesi alt parametrelerinin tümü ile depresyon arasında güçlü pozitif korelasyon vardı (p<0,001). Sonuç: Uyku bozuklukları IPH hastalarında yaygındır ve depresyon ve yaşam kalitesini büyük ölçüde olumsuz etkiler. Parkinson hastalarında uyku bozukluklarının kontrol altına alınmasıyla yaşam kalitesi artırılabilir.
- 7 March 2026
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (3) , 1-10
Residual immune activation in cidp remission: the contribution of macrophage-derived cytokines and chemokines
Introduction : Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy in which remission does not necessarily imply immunological silence. Persistent low-grade inflammation may continue despite clinical stability. This study aimed to evaluate macrophage-related cytokines and chemokines in CIDP patients during remission compared with healthy controls. Methods We conducted a cross-sectional, case–control study including 30 patients fulfilling the 2021 EAN/PNS diagnostic criteria for CIDP in remission and 30 age- and sex-matched healthy controls. All patients received maintenance intravenous immunoglobulin (IVIg). Clinical status was assessed by INCAT scores, and peripheral blood was collected at least one month after the last IVIg infusion. Serum levels of IL-1β, TNF-α, IL-6, MIP-1α, and MIP-1β were measured by ELISA. Results CIDP patients had significantly higher IL-1β (p < 0.001) and TNF-α (p = 0.002) levels than controls, whereas IL-6, MIP-1α, and MIP-1β did not differ significantly. IL-1β positively correlated with TNF-α and MIP-1α, suggesting a coordinated inflammatory response. ROC analysis demonstrated moderate diagnostic performance for IL-1β (AUC = 0.783) and TNF-α (AUC = 0.733). No association was observed between biomarker levels and electrophysiological parameters. Conclusion Our findings indicate that residual immune activation persists during CIDP remission, with IL-1β and TNF-α emerging as potential biomarkers of subclinical inflammation. Although MIP-1α and MIP-1β were not elevated in remission, their correlation with proinflammatory cytokines suggests that they may be more relevant in the active phase of disease. Longitudinal studies comparing relapse and remission are warranted to clarify their sensitivity as markers of disease activity and to validate their prognostic role.
- 7 March 2026
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (3) , 1-10
Residual immune activation in cidp remission: the contribution of macrophage-derived cytokines and chemokines
Introduction : Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy in which remission does not necessarily imply immunological silence. Persistent low-grade inflammation may continue despite clinical stability. This study aimed to evaluate macrophage-related cytokines and chemokines in CIDP patients during remission compared with healthy controls. Methods We conducted a cross-sectional, case–control study including 30 patients fulfilling the 2021 EAN/PNS diagnostic criteria for CIDP in remission and 30 age- and sex-matched healthy controls. All patients received maintenance intravenous immunoglobulin (IVIg). Clinical status was assessed by INCAT scores, and peripheral blood was collected at least one month after the last IVIg infusion. Serum levels of IL-1β, TNF-α, IL-6, MIP-1α, and MIP-1β were measured by ELISA. Results CIDP patients had significantly higher IL-1β (p < 0.001) and TNF-α (p = 0.002) levels than controls, whereas IL-6, MIP-1α, and MIP-1β did not differ significantly. IL-1β positively correlated with TNF-α and MIP-1α, suggesting a coordinated inflammatory response. ROC analysis demonstrated moderate diagnostic performance for IL-1β (AUC = 0.783) and TNF-α (AUC = 0.733). No association was observed between biomarker levels and electrophysiological parameters. Conclusion Our findings indicate that residual immune activation persists during CIDP remission, with IL-1β and TNF-α emerging as potential biomarkers of subclinical inflammation. Although MIP-1α and MIP-1β were not elevated in remission, their correlation with proinflammatory cytokines suggests that they may be more relevant in the active phase of disease. Longitudinal studies comparing relapse and remission are warranted to clarify their sensitivity as markers of disease activity and to validate their prognostic role.
- Open Access
- 31 December 2025
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 56, 24-29
Phenotypical reflection of a patient with a possible pathological variation of the vcp gene and difficulties in neuromuscular differential diagnosis
The differential diagnosis of muscle weakness includes a wide spectrum of diseases, from cerebrovascular diseases to motor neuron diseases, peripheral neuropathies, neuromuscular junction diseases and myopathies. Although many methods are used to make a diagnosis, including anamnesis, examination, laboratory, electrophysiological examinations, radiological examinations, biopsy and genetic analysis, there are still many patients who cannot be diagnosed. In this article, we present a case in which it was not possible to differentiate between inclusion body myopathy, amyotrophic lateral sclerosis and hereditary motor neuropathy. A 59-year-old male patient presented with chronic progressive muscle weakness and myalgias. The patient, who had complaints for approximately 8-9 years, had a family history supporting an autosomal dominant inheritance pattern. In the patient’s neurological examination, muscle weakness affecting the distal and proximal parts of the bilateral lower and upper extremities, atrophy in the thenar and hypothenar regions of the upper extremity, and hypoactive deep tendon reflexes were detected. Other neurological examinations were normal. Laboratory tests revealed no pathology other than moderate CK elevation. Electrophysiological findings supporting the association of motor neuropathy and myopathy were detected in electromyography. No pathology was detected in muscle biopsy other than mild inflammatory changes. Genetic examination of the patient revealed a heterozygous mutation (c.365C>G protein Thr122Arg) in the T122R variant of the Valosin-containing protein (VCP) gene. When the literature is reviewed, although there are some variants of VCP gene mutations associated with familial inclusion body myopathy, amyotrophic lateral sclerosis accompanied by frontotemporal dementia, and Charcot-Marie-Tooth (CMT) 2Y, this variant in our patient has not been described before. The patient’s family history of autosomal dominant trait and the presence of both IBM and CMT clinics suggest that these two clinics are phenotypically reflected together as a secondary to the current mutation. In this period when genetic treatments are rapidly developing, it is of great importance to identify genetic muscle diseases and new variants, so such cases should be reported. In patients whom differential diagnosis cannot be made, advanced genetic examinations should be performed even if genetic examinations such as NGS are found negative.
- 31 December 2025
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 56, 24-29
Open AccessPhenotypical reflection of a patient with a possible pathological variation of the vcp gene and difficulties in neuromuscular differential diagnosis
The differential diagnosis of muscle weakness includes a wide spectrum of diseases, from cerebrovascular diseases to motor neuron diseases, peripheral neuropathies, neuromuscular junction diseases and myopathies. Although many methods are used to make a diagnosis, including anamnesis, examination, laboratory, electrophysiological examinations, radiological examinations, biopsy and genetic analysis, there are still many patients who cannot be diagnosed. In this article, we present a case in which it was not possible to differentiate between inclusion body myopathy, amyotrophic lateral sclerosis and hereditary motor neuropathy. A 59-year-old male patient presented with chronic progressive muscle weakness and myalgias. The patient, who had complaints for approximately 8-9 years, had a family history supporting an autosomal dominant inheritance pattern. In the patient’s neurological examination, muscle weakness affecting the distal and proximal parts of the bilateral lower and upper extremities, atrophy in the thenar and hypothenar regions of the upper extremity, and hypoactive deep tendon reflexes were detected. Other neurological examinations were normal. Laboratory tests revealed no pathology other than moderate CK elevation. Electrophysiological findings supporting the association of motor neuropathy and myopathy were detected in electromyography. No pathology was detected in muscle biopsy other than mild inflammatory changes. Genetic examination of the patient revealed a heterozygous mutation (c.365C>G protein Thr122Arg) in the T122R variant of the Valosin-containing protein (VCP) gene. When the literature is reviewed, although there are some variants of VCP gene mutations associated with familial inclusion body myopathy, amyotrophic lateral sclerosis accompanied by frontotemporal dementia, and Charcot-Marie-Tooth (CMT) 2Y, this variant in our patient has not been described before. The patient’s family history of autosomal dominant trait and the presence of both IBM and CMT clinics suggest that these two clinics are phenotypically reflected together as a secondary to the current mutation. In this period when genetic treatments are rapidly developing, it is of great importance to identify genetic muscle diseases and new variants, so such cases should be reported. In patients whom differential diagnosis cannot be made, advanced genetic examinations should be performed even if genetic examinations such as NGS are found negative.
- 5 August 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109092
Comparison of the effects of greater occipital nerve blockage versus combined greater occipital nerve and supraorbital nerve blockage therapy on sleep, pain, anxiety, depression, and quality of life in chronic migraine
- 5 August 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109092
Comparison of the effects of greater occipital nerve blockage versus combined greater occipital nerve and supraorbital nerve blockage therapy on sleep, pain, anxiety, depression, and quality of life in chronic migraine
- Open Access
- 1 June 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (06) , 001-008
Innsbruck REM Sleep Behavior Disorder Inventory may distinguish abnormal nocturnal movements related to obstructive sleep apnea
Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by recurrent dream enactment behaviors like sleep-related vocalization and/or complex motor behaviors.To investigate the discriminative role of the validated Turkish version of the 9-Item Innsbruck REM Sleep Behavior Disorder Inventory (IRBD-9-Turkish) for idiopathic RBD (iRBD) in patients with obstructive sleep apnea (OSA).The current multicenter study was prospectively conducted in 13 accredited sleep centers in 10 different cities in Türkiye. Clinical data was obtained through a preformed questionnaire, and all participants were submitted to a full-night video-polysomnography (video-PSG) session in a sleep laboratory.A total of 105 patients (mean age: 58.3 ± 11.6 years; 68.6% of male subjects) were prospectively and consecutively enrolled in the study; 51 patients (48.6%) presented iRBD, and 54 (51.4%), OSA, 19 (35.2%) of whom presented abnormal nocturnal behaviors (NBs) demonstrated by clinical and video-PSG findings associated with arousal reactions secondary to apneas and hypopneas. The cut-off value of the IRBD-9 was higher in patients with OSA-NBs than in those with OSA without NBs (p < 0.001), with a sensitivity of 0.765 and a specificity of 0.667, resulting in a correct diagnosis of NBs in 75% of patients with OSA. The receiver operating characteristic (ROC) curves for Factor I (items 1, 2, 3, 6, and 8) and Factor II (items 4, 5, 7, and 9) of the IRBD-9-Turkish showed that both factors were able to distinguish patients with iRBD from those with OSA, but only Factor I distinguishes patients with iRBD from those with OSA-NBs.The present study demonstrated a very high sensitivity and specificity of the IRBD-9-Turkish not only in patients with iRBD, but also in patients with OSA.
- 1 June 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (06) , 001-008
Open AccessInnsbruck REM Sleep Behavior Disorder Inventory may distinguish abnormal nocturnal movements related to obstructive sleep apnea
Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by recurrent dream enactment behaviors like sleep-related vocalization and/or complex motor behaviors.To investigate the discriminative role of the validated Turkish version of the 9-Item Innsbruck REM Sleep Behavior Disorder Inventory (IRBD-9-Turkish) for idiopathic RBD (iRBD) in patients with obstructive sleep apnea (OSA).The current multicenter study was prospectively conducted in 13 accredited sleep centers in 10 different cities in Türkiye. Clinical data was obtained through a preformed questionnaire, and all participants were submitted to a full-night video-polysomnography (video-PSG) session in a sleep laboratory.A total of 105 patients (mean age: 58.3 ± 11.6 years; 68.6% of male subjects) were prospectively and consecutively enrolled in the study; 51 patients (48.6%) presented iRBD, and 54 (51.4%), OSA, 19 (35.2%) of whom presented abnormal nocturnal behaviors (NBs) demonstrated by clinical and video-PSG findings associated with arousal reactions secondary to apneas and hypopneas. The cut-off value of the IRBD-9 was higher in patients with OSA-NBs than in those with OSA without NBs (p < 0.001), with a sensitivity of 0.765 and a specificity of 0.667, resulting in a correct diagnosis of NBs in 75% of patients with OSA. The receiver operating characteristic (ROC) curves for Factor I (items 1, 2, 3, 6, and 8) and Factor II (items 4, 5, 7, and 9) of the IRBD-9-Turkish showed that both factors were able to distinguish patients with iRBD from those with OSA, but only Factor I distinguishes patients with iRBD from those with OSA-NBs.The present study demonstrated a very high sensitivity and specificity of the IRBD-9-Turkish not only in patients with iRBD, but also in patients with OSA.